Search research articles
Contact Us
Filters
Showing results (1-10 of 225) with videos related to
Page
of 23
Sort By:
Expert Review of Molecular Diagnostics
|
March 17, 2011
Personalized hepatitis C therapy: opportunities and pitfalls
Andri Rauch, Jacques Fellay
The Lancet. Gastroenterology & Hepatology
|
November 20, 2020
Hepatitis C among men who have sex with men: knowing your epidemic
Andri Rauch, Gilles Wandeler
AIDS (London, England)
|
November 10, 2011
Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient
Gilles Wandeler, Hansjakob Furrer, Andri Rauch
Journal of Investigative Medicine High Impact Case Reports
|
September 30, 2017
Recurrent Inflammatory Flares in HIV-Infected Patients: Consider Castleman Disease!
Sabrina Jegerlehner, Andri Rauch, Urban Novak
European Journal of Clinical Investigation
|
July 14, 2010
The recent breakthroughs in the understanding of host genomics in hepatitis C
Andri Rauch, Janine Rohrbach, Pierre-Yves Bochud
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 27, 2005
Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin
Andri Rauch, Martin Egger, Jürg Reichen, et al.
Therapeutische Umschau. Revue Therapeutique
|
August 6, 2014
[Hepatitis B and C in HIV coinfection]
Jan Fehr, Verena Schärer, Cédric Hirzel, et al.
Pharmacogenomics
|
November 7, 2009
Host genetic determinants of spontaneous hepatitis C clearance
Andri Rauch, Silvana Gaudieri, Chloe Thio, et al.
Swiss Medical Weekly
|
February 7, 2015
Hepatitis C: a changing epidemic
Gilles Wandeler, Jean-François Dufour, Philip Bruggmann, et al.
Open Forum Infectious Diseases
|
December 6, 2018
Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
Laura N Walti, Julia Steinrücken, Andri Rauch, et al.
Page
of 23
Search research articles
Search
Showing results (1-10 of 225) with videos related to
Sort By:
Page
of 23
Expert Review of Molecular Diagnostics
|
March 17, 2011
Personalized hepatitis C therapy: opportunities and pitfalls
Andri Rauch, Jacques Fellay
The Lancet. Gastroenterology & Hepatology
|
November 20, 2020
Hepatitis C among men who have sex with men: knowing your epidemic
Andri Rauch, Gilles Wandeler
AIDS (London, England)
|
November 10, 2011
Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient
Gilles Wandeler, Hansjakob Furrer, Andri Rauch
Journal of Investigative Medicine High Impact Case Reports
|
September 30, 2017
Recurrent Inflammatory Flares in HIV-Infected Patients: Consider Castleman Disease!
Sabrina Jegerlehner, Andri Rauch, Urban Novak
European Journal of Clinical Investigation
|
July 14, 2010
The recent breakthroughs in the understanding of host genomics in hepatitis C
Andri Rauch, Janine Rohrbach, Pierre-Yves Bochud
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 27, 2005
Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin
Andri Rauch, Martin Egger, Jürg Reichen, et al.
Therapeutische Umschau. Revue Therapeutique
|
August 6, 2014
[Hepatitis B and C in HIV coinfection]
Jan Fehr, Verena Schärer, Cédric Hirzel, et al.
Pharmacogenomics
|
November 7, 2009
Host genetic determinants of spontaneous hepatitis C clearance
Andri Rauch, Silvana Gaudieri, Chloe Thio, et al.
Swiss Medical Weekly
|
February 7, 2015
Hepatitis C: a changing epidemic
Gilles Wandeler, Jean-François Dufour, Philip Bruggmann, et al.
Open Forum Infectious Diseases
|
December 6, 2018
Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
Laura N Walti, Julia Steinrücken, Andri Rauch, et al.
Page
of 23